Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.
Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
VitalConnect offers wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations.
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
Twin Health is a metabolic health platform that offers sensors, AI to reverse, prevent and improve chronic metabolic diseases.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Orpyx Medical Technologies develops sensor-based technologies and self-monitoring devices in medical and athletic spaces.
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Bridge to Life is a supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion.
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
Adaptilens is a developer of an accommodating intraocular lens.
Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.
AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.
VivoSense is an advancing clinical research with wearable sensor solutions.
Cue is a healthcare technology company that enables people to manage their health through actionable and connected health data.
AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors.
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
Perceptive Advisors has invested in 224 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Biopharma. The firm invests across 24 different industry categories.
Among tracked funding rounds, Kardigan received $254.0M in a Series B round. Perceptive Advisors's total known invested capital is $26.6B.
Perceptive Advisors's average investment size is $135.1M across its portfolio of 224 companies.
Recent Perceptive Advisors portfolio additions include GenSight Biologics, Juno Diagnostics, Applied Therapeutics, COMPASS Pathways, Beam Therapeutics. These companies were founded in 2020 or later.